Usana Health Sciences Inc (USNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Sales | 191,944 | 188,256 | 182,401 | 186,266 | 173,691 |
| Cost of Goods | 34,585 | 34,865 | 33,828 | 33,778 | 31,491 |
| Gross Profit | 157,359 | 153,391 | 148,573 | 152,488 | 142,200 |
| Operating Expenses | 128,689 | 125,169 | 124,279 | 124,262 | 117,997 |
| Operating Income | 29,255 | 29,087 | 25,122 | 29,004 | 24,694 |
| Interest Expense | 5 | 0 | 6 | 0 | 0 |
| Other Income | -292 | 297 | 131 | -98 | 76 |
| Pre-tax Income | 28,958 | 29,384 | 25,247 | 28,906 | 24,770 |
| Income Tax | 9,460 | 10,083 | 8,710 | 8,624 | 8,017 |
| Net Income Continuous | 19,498 | 19,301 | 16,537 | 20,282 | 16,753 |
| Net Income | $19,498 | $19,301 | $16,537 | $20,282 | $16,753 |
| EPS Basic Total Ops | 0.76 | 0.70 | 0.60 | 0.73 | 0.61 |
| EPS Basic Continuous Ops | 0.76 | 0.70 | 0.59 | 0.73 | 0.61 |
| EPS Diluted Total Ops | 0.74 | 0.68 | 0.58 | 0.70 | 0.58 |
| EPS Diluted Continuous Ops | 0.74 | 0.68 | 0.57 | 0.70 | 0.58 |
| EBITDA(a) | $31,532 | $31,284 | $27,333 | $31,178 | $26,933 |